Clinical characteristics, outcome of scleromyxoedema: A retrospective multicentre study;Caractéristiques cliniques et évolutives du scléromyxœdème: Étude rétrospective multicentrique

Annales de Dermatologie et de Venereologie

Volumn 137, Issue 12, 2010, Pages 782-788

  Le Moigne, M ^a   Mazereeuw Hautier, J ^a   Bonnetblanc, J M ^b   Astudillo, L ^c   D'Incan, M ^d   Bessis, D ^e   Thomas, L ^f   Debarbieux, S ^f   Ammoury, A ^a   Lamant, L ^c   Paul, C ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

^f HOSPICES CIVILS DE LYON   (France)

Author keywords

Arndt Gottron scleromyxoedema; Mucinosis; Scleromyxoedema

Indexed keywords

DEXAMETHASONE; MUCIN; THALIDOMIDE;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FOLLOW UP; HUMAN; INTERSTITIAL PNEUMONIA; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; PERIPHERAL NEUROPATHY; REMISSION; SCLEROMYXEDEMA; SKIN FIBROSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADRENAL CORTEX HORMONES; ADULT; AGED; BIOPSY; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROBLASTS; FOLLOW-UP STUDIES; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDIES; SCLEROMYXEDEMA; SKIN; THALIDOMIDE;

EID: 79251629466     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2010.08.011     Document Type: Article

References (39)

1. F. Rongioletti, and A. Rebora Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema J Am Acad Dermatol 44 2001 273 281
2. Saurat JH, Lachapelle JM, Lipsker D, Thomas L. Dermatologie et infections sexuellement transmissibles. Paris: Masson; 2008. p. 581-5.
3. M. Amini-Adle, N. Thieulent, S. Dalle, B. Balme, and L. Thomas Scleromyxedema: successful treatment with thalidomide in two patients Dermatology 214 2007 58 60
4. L.M. Peter, A. Ammoury, H. Chiavassa-Gandois, L. Lamant, and C.F. Paul Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide Clin Exp Dermatol 33 2008 606 610
5. J.M. Bonnetblanc, and C. Bedane Regression of scleromyxedema with topical betamethasone and dimethyl sulfoxide: a 30-month follow-up Arch Dermatol 127 1991 1733 1734
6. M. D'Incan, F. Franck, J. Kanold, F. Bacin, R. Achin, and A.J. Beyvin Mucinose papuloscléreuse (scléromyxoedme) cutanéo- systémique. Rémission aprs photochimiothérapie extracorporelle et bolus de corticoïdes Ann Dermatol Venereol 128 2001 38 41
7. W. Heymann, and Scleromyxedema J Am Acad Dermatol 57 2007 890 891
8. P. Morales, M.A. Martinez, F. Vera, and G. Romero Severe lung involvement in systemic scleromyxoedema: a highly unusual finding Eur Respir J 19 2002 976 979
9. J.R. Berger, M.R. Dobbs, M.H. Terhune, and W.F. Maragos The neurologic complications of scleromyxedema Medicine (Baltimore) 80 2001 313 319
10. J.B. Rey, and R.B. Luria Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin J Am Acad Dermatol 60 2009 1037 1041
11. S.E. Gabriel, H.O. Perry, G.B. Oleson, and C.A. Bowles Scleromyxedema: a scleroderma-like disorder with systemic manifestations Medicine (Baltimore) 67 1988 58 65
12. J.J. Pomann, and E.J. Rudner Scleromyxedema revisited Int J Dermatol 42 2003 31 35
13. A. Dinneen, and C. Dicken Scleromyxedema J Am Acad Dermatol 33 1995 37 41
14. R.A. Harper, and J. Rispler Lichen myxedematosus serum stimulates human skin fibroblast proliferation Science 199 1978 545 547
15. M. Ferrarini, D.J. Helfrich, E.R. Walker, T.A. Medsger Jr., and T.L. Whiteside Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts J Rheumatol 16 1989 837 841
16. J.J. Chanda Scleromyxedema Cutis 24 1979 549 552
17. A. Godby, P. Bergstresser, B. Chaker, and A. Pandya Fatal scleromyxedema: report of a case and review of the literature J Am Acad Dermatol 38 1998 289 294
18. M. Laimer, K. Namberger, C. Massone, J. Koller, M. Emberger, and L. Pleyer Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema Acta Derm Venereol 89 2009 631 635
19. J.C. Sansbury, B. Cocuroccia, J.L. Jorizzo, E. Gubinelli, P. Gisondi, and G. Girolomoni Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients J Am Acad Dermatol 51 2004 126 131
20. S. Caradonna, and H. Jacobe Thalidomide as a potential treatment for scleromyxedema Arch Dermatol 140 2004 277 280
21. J.P. Thyssen, C. Zachariae, and T. Menne Successful treatment of scleromyxedema using thalidomide J Eur Acad Dermatol Venereol 20 2006 1396 1397
22. S.E. Jacob, S. Fien, and F.A. Kerdel Scleromyxedema, a positive effect with thalidomide Dermatology 213 2006 150 152
23. T. Cheng, V. Gnanakumar, C. Hegedus, and D.A. Stewart Complete and durable remission in a patient with life-threatening scleromyxedema treated with high-dose melphalan and BU with auto-SCT Bone Marrow Transplant 42 2008 215 217
24. M.Q. Lacy, W.J. Hogan, M.A. Gertz, A. Dispenzieri, S.V. Rajkumar, and S. Hayman Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation Arch Dermatol 141 2005 1277 12782
25. M.L. Donato, A.M. Feasel, D.M. Weber, V.G. Prieto, S.A. Giralt, and R.E. Champlin Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation Blood 107 2006 463 466
26. P. Efthimiou, and M. Blanco Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature Semin Arthritis Rheum 38 2008 188 194
27. K. Schubert, A. Stein, and M. Meurer Initial scleromyxedema. Successful treatment with melphalan Hautarzt 53 2002 478 482
28. P. Feldman, L. Shapiro, A.I. Pick, and M.H. Slatkin Scleromyxedema. A dramatic response to melphalan Arch Dermatol 99 1969 51 56
29. P. Terheyden, J.C. Becker, C. Lurz, G.J. Kahaly, and E.B. Bröcker Treatment of scleromyxedema with hydroxychloroquine J Dtsch Dermatol Ges 1 2003 30 35
30. W. Aberer, and K. Wolff Scleromyxedema: immunosuppressive therapy with cyclophosphamide Hautarzt 39 1988 277 280
31. C.M. Kuldeep, A.K. Mittal, L.K. Gupta, V.K. Paliwal, P. Sharma, and A. Garg Successful treatment of scleromyxedema with dexamethasone cyclophosphamide pulse therapy Indian J Dermatol Venereol Leprol 71 2005 44 45
32. D.S. Nieves, E.E. Bondi, J. Wallmark, E.C. Raps, and J.T. Seykora Scleromyxedema: successful treatment of cutaneous and neurologic symptoms Cutis 65 2000 89 92
33. L.S. Davis, S. Sanal, and O.P. Sangueza Treatment of scleromyxedema with 2-chlorodeoxyadenosine J Am Acad Dermatol 35 1996 288 290
34. C.P. Milam, L.E. Cohen, N.A. Fenske, and N.S. Ling Scleromyxedema: therapeutic response to isotretinoin in three patients J Am Acad Dermatol 19 1988 469 477
35. B.M. Hisler, L.B. Savoy, and K. Hashimoto Improvement of scleromyxedema associated with isotretinoin therapy J Am Acad Dermatol 24 1991 854 857
36. C.H. Keong, Y. Asaka, S. Fukuro, C. Miyamoto, M. Katsumata, and Y. Iino Successful treatment of scleromyxedema with plasmapheresis and immunosuppression J Am Acad Dermatol 22 1990 842 844
37. A.I. Westheim, and D.P. Lookingbill Plasmapheresis in a patient with scleromyxedema Arch Dermatol 123 1987 786 789
38. J.A. Tschen, and J.R. Chang Scleromyxedema: treatment with interferon alfa J Am Acad Dermatol 40 1999 303 307
39. N.J. Lowe, P.A. Dufton, R.D. Hunter, and C.F. Vickers Electron-beam treatment of scleromyxoedema Br J Dermatol 106 1982 449 453